1. Home
  2. COYA

COYA

Coya Therapeutics Inc.

Logo Coya Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Founded: 2020 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 131.7M IPO Year: 2022
Target Price: $19.00 AVG Volume (30 days): 97.2K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.79 EPS Growth: N/A
52 Week Low/High: $3.21 - $10.69 Next Earning Date: 05-08-2024
Revenue: $6,002,206 Revenue Growth: N/A
Revenue Growth (this year): 42.75% Revenue Growth (next year): 19.05%

Share on Social Networks: